X-153953662-G-A
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 1P and 16B. PP2BP4_StrongBP6_Very_StrongBS2
The ENST00000310441.12(HCFC1):c.4442C>T(p.Thr1481Met) variant causes a missense change. The variant allele was found at a frequency of 0.000354 in 1,209,424 control chromosomes in the GnomAD database, including 1 homozygotes. There are 136 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. T1481T) has been classified as Likely benign.
Frequency
Consequence
ENST00000310441.12 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -15 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HCFC1 | NM_005334.3 | c.4442C>T | p.Thr1481Met | missense_variant | 18/26 | ENST00000310441.12 | NP_005325.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HCFC1 | ENST00000310441.12 | c.4442C>T | p.Thr1481Met | missense_variant | 18/26 | 1 | NM_005334.3 | ENSP00000309555 | P2 | |
HCFC1 | ENST00000369984.4 | c.4442C>T | p.Thr1481Met | missense_variant | 18/26 | 5 | ENSP00000359001 | A2 | ||
HCFC1 | ENST00000444191.5 | c.167C>T | p.Thr56Met | missense_variant | 2/10 | 5 | ENSP00000399589 |
Frequencies
GnomAD3 genomes AF: 0.000329 AC: 37AN: 112430Hom.: 0 Cov.: 24 AF XY: 0.000434 AC XY: 15AN XY: 34578
GnomAD3 exomes AF: 0.00115 AC: 207AN: 180011Hom.: 1 AF XY: 0.000973 AC XY: 65AN XY: 66815
GnomAD4 exome AF: 0.000356 AC: 391AN: 1096944Hom.: 1 Cov.: 31 AF XY: 0.000334 AC XY: 121AN XY: 362740
GnomAD4 genome AF: 0.000329 AC: 37AN: 112480Hom.: 0 Cov.: 24 AF XY: 0.000433 AC XY: 15AN XY: 34638
ClinVar
Submissions by phenotype
not specified Benign:2
Benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 15, 2016 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
HCFC1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 16, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Methylmalonic acidemia with homocystinuria, type cblX Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
not provided Benign:1
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at